首页> Cancer immunology, immunotherapy : CII> Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.

Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.

导出 OA

翻译打印收藏纠错

第一作者： Lata,Singh

第一单位： Department of Biosciences, Jamia Millia Islamia, New Delhi, India.;Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India.

作者： Lata,Singh ^[1] ; Mithalesh Kumar,Singh ^[2] ; Moshahid Alam,Rizvi ^[3] ; Sameer,Bakhshi ^[4] ; Rachna,Meel ^[5] ; Neiwete,Lomi ^[5] ; Seema,Sen ^[2] ; Seema,Kashyap ^[6]

作者单位： Department of Biosciences, Jamia Millia Islamia, New Delhi, India.;Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India. ^[1] Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India. ^[2] Department of Biosciences, Jamia Millia Islamia, New Delhi, India. ^[3] Department of Medical Oncology, IRCH, All India Institute of Medical Sciences, New Delhi, India. ^[4] Department of Ophthalmology, Dr. R. P. Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. ^[5] Department of Ocular Pathology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 110029, India. dr_skashyap@hotmail.com. ^[6]

关键词 Cancer immunotherapy Chemotherapy Histopathology Immune checkpoint markers Retinoblastoma